Spesolimab may improve quality of life in patients with generalized pustular psoriasis flares
1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up...
1. Efficacy of spesolimab appeared to be dose-dependent with high-dose spesolimab leading to a significantly longer time to GPP flare-up...
1. 3-dimensional (3D) stereophotogrammetry identified craniofacial morphea (CM) progression in patients with clinically reported disease activity. 2. 3D stereophotogrammetry identified...
1. Skin-related quality of life is associated with the type of autoimmune bullous disease and flare state. 2. Skin-related quality...
1. The current randomized controlled trial is the first of its kind to demonstrate the efficacy of maggot debridement therapy...
1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in the observation group. 2....
1. Mohs micrographic surgery was associated with significantly higher survival rates for patients with T1/T2 Merkel cell carcinoma with pathologically...
1. Nemolizumab may reduce inflammatory, neural, and epithelial signalling in patients with prurigo nodularis by inhibiting IL-31. 2. Nemolizumab may...
1. Anxiety and depression were more prevalent among individuals with eczema or psoriasis, and those with these inflammatory conditions were...
1. Dupilumab treatment for bullous pemphigoids resulted in improved clinical symptoms. 2. Patients with anti-BP180 antibody levels of at least...
1. In this prospective cohort study, there was an increased incidence of physician-confirmed decompression illness (DCI) in divers with high-risk...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.